Siemens Healthineers Archives - Page 7 of 7

AdvaMed unveils COVID-19 diagnostic supply registry

AdvaMed announced today that it created a comprehensive national COVID-19 diagnostic supply registry to aid state and federal pandemic responses.

According to a news release, AdvaMed is launching the registry in partnership with 13 commercial diagnostics manufacturers: Abbott (NYSE:ABT), Becton Dickinson (NYSE:BDX), bioMérieux, Bio-Rad Laboratories (NYSE:BIO), Beckman Coulter, Cepheid, Hologic (NSDQ:HOLX), Ortho Clinical Diagnostics, Qiagen (NYSE:QGEN), Roche Diagnostics, Sekisui Diagnostics, Siemens Healthineers (ETR: SHL), and Thermo Fisher Scientific (NYSE:TMO).

The AdvaMed registry is designed to compile information from the diagnostic companies, along with public data, to create a centralized and standardized COVID-19 diagnostic supply registry to update on weekly numbers at state and national levels regarding molecular, antigen and serology tests shipped in the U.S.

AdvaMed said in the release that the registry will also help streamline communicati…

Siemens Healthineers, DHL Supply Chain to create distribution facility in Memphis

[Distribution center rendering courtesy of DHL]

Siemens Healthineers (ETR: SHL) and DHL Supply Chain announced today that they have inked a comprehensive U.S. service logistics agreement.

The agreement includes the two companies creating a 260,000 ft2 distribution center that DHL will operate in Memphis, Tenn.

Get the full story on our sister site Medical Design & Outsourcing.

Siemens Healthineers, DHL Supply Chain to create distribution facility in Memphis

[Distribution center rendering courtesy of DHL]

Siemens Healthineers (ETR: SHL) and DHL Supply Chain announced today that they have inked a comprehensive U.S. service logistics agreement.

The agreement includes the two companies creating a 260,000 ft2 distribution center that DHL will operate in Memphis, Tenn.

Under a 10-year service agreement, the Siemens Healthineers distribution operation will occupy more than half of a 422,000 square foot facility that DHL has purchased. The operation will employ about 105 people.

The World Distribution Center will incorporate DHL’s proprietary warehousing and inventory management system. DHL also boasts innovations to boost efficiency and productivity, including automated storage and retrieval systems and augmented reality–assisted picking.

“The Americas is an important growth market for Siemens Healthineers, and the quality, flexibility and speed of t…

Siemens Healthineers wins EUAs for additional COVID-19 antibody tests

More than a week after granting EUAs for COVID-19 antibody tests produced by Siemens Healthineers (ETR: SHL), FDA has authorized additional tests from the German medtech giant.

The new EUAs, granted June 8, are for tests running on Siemens Healthineers Dimension Vista and Dimension® EXL systems. The tests already started shipping on May 29.

Siemens Healthineers previously announced EUAs for comparable tests running on Atellica IM immunoassay analyzers and Advia Centaur XP and XPT analyzers.

The company is making the tests in Walpole, Mass. and Newark, Del., and distributing them out of Plainfield, Ind. It’s ramping up production, with a goal of manufacturing capacity exceeding 50 million tests per month across its testing platforms.

Siemens, Geisinger ink 10-year deal

Siemens Healthineers (ETR: SHL) and Geisinger Health have signed a 10-year deal for Siemens to provide digital health innovations, diagnostic imaging equipment and on-site staff support.

Siemens will also provide education and workflow resources to the staff of Danville, Pa.-based Geisinger Health. The contract marks an expansion of a previous relationship between the health system and Siemens.

Get the full story on our sister site, Medical Design & Outsourcing.

Siemens Healthineers secures EUA for its COVID-19 antibody test

Siemens Healthineers (ETR: SHL) announced today that it has secured an FDA emergency use authorization for its COVID-19 antibody test.

The news comes nearly a week after the German medtech giant said it had started worldwide shipments of the test — a laboratory-based total antibody test that can detect SARS-CoV-2 antibodies including IgM and IgG in blood. The company already has more than 1 million tests shipped to health systems and laboratories.

Antibody tests are an important tool as countries reopen their economies amid the COVID-19 pandemic: They can tell who has had the coronavirus in the past and hopefully developed some immunity. Siemens Healthineers, in fact, designed its Total Antibody COV2T assay to detect antibodies to the spike protein, which are believed to neutralize the SARS-CoV-2 virus and therefore prevent infection.

“As a leader in laboratory diagnostics, Siemens Healthineers designed a high-quality, highly accurate antibody test with …

Siemens Healthineers to produce 50m antibody tests per month against COVID-19

Siemens Healthineers (ETR: SHL) said today that it has started worldwide shipments of its COVID-19 antibody test, with a goal of producing 50 million tests per month as the pandemic evolves.

The German medtech giant boasts that it has 20,000 systems worldwide to run the tests, including what it describes as the largest analyzer installed base in the U.S. Siemens Healthineers is increasing test production at its Walpole (Walpole, Mass.) and Glasgow (Newark, Del.) facilities so that it can exceed 50 million tests per month starting in June.

Get the full story on our sister site MassDevice.

Siemens Healthineers to produce 50m antibody tests per month against COVID-19

Siemens Healthineers (ETR: SHL) said today that it has started worldwide shipments of its COVID-19 antibody test, with a goal of producing 50 million tests per month as the pandemic evolves.

The German medtech giant also announced that FDA has granted an emergency use authorization for its PCR Fast Track Diagnostics (FTD) SARS-CoV-2 Assay6 test kit.

Both types of tests are important: Antibody tests can tell who has had the coronavirus in the past and hopefully developed some immunity, while people need diagnostics tests to tell whether they are experiencing a COVID-19 infection right now.

Siemens officials say the company’s antibody tests demonstrate 100% sensitivity (ability to exclude false negatives) and 99.8% specificity (few false positives) in identifying SARS-CoV-2 antibodies in as few as 10 minutes. The tests have a CE Mark in the EU, and Siemens is seeking an FDA EUA.

Siemens boasts that it has 20,000 systems worldwide to run the t…